Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 29;9(2):322.
doi: 10.3390/cells9020322.

Angiotensin-II-Evoked Ca2+ Entry in Murine Cardiac Fibroblasts Does Not Depend on TRPC Channels

Affiliations

Angiotensin-II-Evoked Ca2+ Entry in Murine Cardiac Fibroblasts Does Not Depend on TRPC Channels

Juan E Camacho Londoño et al. Cells. .

Abstract

TRPC proteins form cation conducting channels regulated by different stimuli and are regulators of the cellular calcium homeostasis. TRPC are expressed in cardiac cells including cardiac fibroblasts (CFs) and have been implicated in the development of pathological cardiac remodeling including fibrosis. Using Ca2+ imaging and several compound TRPC knockout mouse lines we analyzed the involvement of TRPC proteins for the angiotensin II (AngII)-induced changes in Ca2+ homeostasis in CFs isolated from adult mice. Using qPCR we detected transcripts of all Trpc genes in CFs; Trpc1, Trpc3 and Trpc4 being the most abundant ones. We show that the AngII-induced Ca2+ entry but also Ca2+ release from intracellular stores are critically dependent on the density of CFs in culture and are inversely correlated with the expression of the myofibroblast marker α-smooth muscle actin. Our Ca2+ measurements depict that the AngII- and thrombin-induced Ca2+ transients, and the AngII-induced Ca2+ entry and Ca2+ release are not affected in CFs isolated from mice lacking all seven TRPC proteins (TRPC-hepta KO) compared to control cells. However, pre-incubation with GSK7975A (10 µM), which sufficiently inhibits CRAC channels in other cells, abolished AngII-induced Ca2+ entry. Consequently, we conclude the dispensability of the TRPC channels for the acute neurohumoral Ca2+ signaling evoked by AngII in isolated CFs and suggest the contribution of members of the Orai channel family as molecular constituents responsible for this pathophysiologically important Ca2+ entry pathway.

Keywords: Ca2+ release and Ca2+ entry; TRPC channels; angiotensin II; cardiac fibroblasts (CFs).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Characterization of primary isolated murine cardiac fibroblasts. (A) Isolated primary CFs from adult mice were cultured at high (>300 cells/mm2) and low density as depicted. Phase contrast images showing the typical morphology and confluence of cultured fibroblasts at several time points of the culture are included. (B) Immunocytochemical characterization of primary cultures of CFs using antibodies against α-actinin, α-smooth muscle (SM) actin, P4HB and CD31 (Bi) or additionally DDR2 (Bii) is shown. (C) Expression analysis by qPCR from Trpc channels in four independent (n = 4 hearts) primary cultures of CFs. bp: base pair. * p < 0.05 depicted are according to Dunn’s post-hoc comparisons after Kruskal-Wallis.
Figure 2
Figure 2
Changes in intracellular Ca2+ concentration in cardiac fibroblasts depending on the density of the culture. (A,B) AngII-induced Ca2+ transients in primary CFs in the presence of 2 mM extracellular Ca2+. Cells were analyzed 5 days after isolation and cultivation at low (A) or high density (B). Fluorescence images of Fura-2 loaded cells are included. (C,D) AngII-induced Ca2+ release from internal stores and subsequent AngII-induced Ca2+ entry were analyzed in fibroblasts maintained at low (C) or high density (D) conditions. Additionally, the expression of α-SM-actin was analyzed on cells cultured on each cell density (upper panels). n = number of independent preparations (hearts).
Figure 3
Figure 3
AngII-induced Ca2+ release and Ca2+ entry in the absence of TRPC3/C6 or after TGF-β pre-treatment. (A) AngII-induced Ca2+ release and Ca2+ entry in primary CFs from WT (black) and TRPC3/C6-DKO (red) mice. Ca2+ release was measured in the absence of extracellular Ca2+ (300 µM EGTA) and Ca2+ entry was monitored in the presence of 2 mM extracellular Ca2+. Left panels: Original traces and right panels: Mean values from three independent preparations (hearts). (B) Measurements performed as in (A) but in cells pre-incubated (10 min) with the TRPC3/C6/C7 antagonist SAR7334 (1 µM). (C) AngII-induced Ca2+ release and Ca2+ entry in primary CFs from WT mice cultivated in the presence of 10 ng/mL TGF-β (green) or under control conditions (black). Left panel: α-actin smooth muscle staining after TGF-β treatment, middle panels: Original traces from Ca2+ measurements and right panels: Mean values from 3 independent preparations. n = number of independent preparations (hearts). All cells were analyzed 5 days after isolation and were cultured at high density. * p < 0.05 according to the unpaired Student’s t-test.
Figure 4
Figure 4
AngII-induced Ca2+ release and Ca2+ entry in cardiac fibroblasts in the absence of all seven TRPC proteins. (A) AngII- and (B) thrombin-induced Ca2+ transients in primary CFs from WT (black) and TRPC-hepta (Trpc1/2/3/4/5/6/7–/–) KO (red) mice. Ca2+ transients were measured in the presence of 2 mM extracellular Ca2+. Left panels: Original traces and right panels: Mean values of three independent preparations (hearts). (C) AngII-induced Ca2+ release and Ca2+ entry in primary CFs from WT (black) and TRPC-hepta KO (red) mice. Ca2+ release was measured in the absence of extracellular Ca2+ (300 µM EGTA) and Ca2+ entry was monitored in the in the presence of 2 mM extracellular Ca2+. Left panels: Original traces and right panels: Mean values of three independent preparations. (D) The effect of the CRAC blocker (10 µM) GSK7975A on the AngII-induced Ca2+ release was analyzed in CFs from WT mice like in (C). Left panels: Original traces and right panels: Mean values of three independent preparations. n = number of independent preparations (hearts). All cells were analyzed 5 days after isolation and were cultured at high density. * p < 0.05 and ** p < 0.01 according to the unpaired Student’s t-test.

Similar articles

Cited by

References

    1. European Association for the Study of the Liver (EASL) European Association for the Study of Diabetes (EASD) European Association for the Study of Obesity (EASO) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 2016;64:1388–1402. doi: 10.1016/j.jhep.2015.11.004. - DOI - PubMed
    1. Chalasani N., Younossi Z., Lavine J.E., Charlton M., Cusi K., Rinella M., Harrison S.A., Brunt E.M., Sanyal A.J. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328–357. doi: 10.1002/hep.29367. - DOI - PubMed
    1. Travers J.G., Kamal F.A., Robbins J., Yutzey K.E., Blaxall B.C. Cardiac Fibrosis: The Fibroblast Awakens. Circ. Res. 2016;118:1021–1040. doi: 10.1161/CIRCRESAHA.115.306565. - DOI - PMC - PubMed
    1. Humeres C., Frangogiannis N.G. Fibroblasts in the Infarcted, Remodeling, and Failing Heart. JACC Basic Transl. Sci. 2019;4:449–467. doi: 10.1016/j.jacbts.2019.02.006. - DOI - PMC - PubMed
    1. Brown R.D., Ambler S.K., Mitchell M.D., Long C.S. The cardiac fibroblast: Therapeutic target in myocardial remodeling and failure. Annu. Rev. Pharm. Toxicol. 2005;45:657–687. doi: 10.1146/annurev.pharmtox.45.120403.095802. - DOI - PubMed

Publication types